Annihilyzer® System Tests Successfully Concluded at Multiple Hospitals Leading to Long-term Service Contracts

LITTLE RIVER, S.C., May 31, 2018 (GLOBE NEWSWIRE) -- PCT LTD PCTL (formerly, Bingham Canyon Corporation) BGHM, a leading provider of green cleaning, sanitizing and disinfecting solutions, reports that it has successfully concluded the In-Hospital Beta Trials of its Annihilyzer^® Infection Control System to alleviate the growing problem of Hospital Acquired Infections (HAIs).

Soon after installation of the first Annihilyzer^® Infection Control System at Johnston UNC Health Care Hospital, Annihilyzer^® Infection Control Systems were also installed at SUNY Downstate Medical Center, Brooklyn, NY, and Fairfield University Nursing School, Fairfield, CT in January 2018 for pre-contract trials and demonstrations.  The Company used the initial four to five-months, December 2017 through April 2018, phase of operations at these three institutions as a Beta Test evaluation of the Annihilyzer^® Infection Control System's performance while being employed by hospital personnel in the hospital facilities settings. 

The Beta Test is an external (real world) pilot-test of a product before commercial quantity production.  The Annihilyzer^® System had passed through extensive, internal testing at the PCT R&D facility in Little River, SC; but, some minor problems require user participation to become apparent.  At these three Beta Partner facilities, the Annihilyzer^® System was tested under normal, everyday conditions of use by hospital and nursing school staff to identify any remaining issues.

Beta Program Results
As expected a number of issues were identified and all successfully resolved.  The results of the hospital trials in the various applications and settings helped to improve the hardware, software, and processes to better meet the needs of the different user groups: management, supervisors and staff.

All three trials resulted in acceptance of the Annihilyzer^® System and equipment by the facility management and long term Annihilyzer^® contracts with the host hospitals, Johnston UNC Health Care and SUNY Downstate Medical, as well as the Fairfield University Nursing School.  The multi-year contracts include physical expansion of the Annihilyzer^® Service with additional Annihilyzer^® Infection Control Systems and related equipment being installed in additional buildings or areas which were not receiving Annihilyzer^® services during the Beta phase.

About PCT
PCT LTD has focused its business on sustainable, environmentally safe technologies and products. The company acquires and holds rights to innovative products and technologies, which are commercialized through operating subsidiaries. Paradigm Convergence Technologies Corporation (PCT Corp) is the wholly owned operating subsidiary of PCT LTD. The business mission of PCT Corp. is in the prevention and control of infectious disease and the pre-harvest prevention, control and suppression of microbial contamination of some commercial crops. PCT Corp designs, develops, integrates, assembles and commercializes technologies, products and systems targeted at the prevention and control of infectious disease and crop pathogens. Its unique and patented systems and human-safe products provide next-generation cleaning, sanitizing and disinfecting fluid solutions to the ever-present problems of microbial infection and infestation.

Forward-Looking Statements
This release contains or may contain forward-looking statements and information that are based upon beliefs of, and information currently available to, management; as well as estimates and assumptions made by management. Such statements reflect the current view of the Company with respect to future events and are subject to risks, uncertainties, assumptions and other factors relating to the Company's industry, operations and results of operations and any businesses that may be acquired by the Company. Should one or more of these risks or uncertainties materialize, or should the underlying assumptions prove incorrect, actual results may differ significantly from those anticipated, believed, estimated, expected, intended or planned.

Contact:
Brokers and Analysts
Chesapeake Group
410-825-3930
info@chesapeakegp.com

Gary Grieco
CEO Paradigm Convergence Technologies
843-390-7900
ggrieco@para-con.com